| Long term treatment of myasthenia gravis with azathioprine. | |
| | |
MedLine Citation:
|
PMID: 2112245 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Twenty-seven patients with myasthenia gravis have been treated with azathioprine in conjunction with pyridostigmine and prednisolone for a total of 138 patient years. Side effects necessitated discontinuation of treatment in only four patients. Treatment with azathioprine was associated with marked clinical improvement in all the remaining 23 patients, resulting in reduction in the dose of pyridostigmine and prednisolone. The number of hospital admissions as well as the number of episodes of respiratory failure were markedly reduced. |
| | |
Authors:
|
V Fonseca; C W Havard |
Related Documents
:
|
11707845 - Biological correlates of acute hypersensitivity events with dab(389)il-2 (denileukin di... 8183775 - Splenectomy in patients with undiagnosed splenomegaly. 17130775 - Pharmacodynamic monitoring of cyclosporine a in renal allograft recipients shows a quan... 21898075 - Delayed treatment with tumor necrosis factor inhibitors in incomplete responders to syn... 8453805 - Amyloidosis in juvenile chronic arthritis: a morbidity and mortality study. 16518985 - Chest radiographic evolution in fat embolism syndrome. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Postgraduate medical journal Volume: 66 ISSN: 0032-5473 ISO Abbreviation: Postgrad Med J Publication Date: 1990 Feb |
Date Detail:
|
Created Date: 1990-07-09 Completed Date: 1990-07-09 Revised Date: 2009-11-18 |
Medline Journal Info:
|
Nlm Unique ID: 0234135 Medline TA: Postgrad Med J Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 102-5 Citation Subset: IM |
Affiliation:
|
Royal Free Hospital, London, UK. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Azathioprine / adverse effects, therapeutic use* Drug Therapy, Combination Female Humans Hypertension, Portal / chemically induced Jaundice / chemically induced Long-Term Care Male Middle Aged Myasthenia Gravis / drug therapy* Prednisolone / therapeutic use Pyridostigmine Bromide / therapeutic use |
| Chemical | |
Reg. No./Substance:
|
101-26-8/Pyridostigmine Bromide; 446-86-6/Azathioprine; 50-24-8/Prednisolone |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Second-line antirheumatic drugs in the elderly with rheumatoid arthritis: a post hoc analysis of thr...
Next Document: Dynamics of accumulation of extracellular lipoteichoic acid in Bacillus cereus